A Study to Evaluate Efficacy and Safety of Oxycodone/Naloxone Compared to OxyContin in Korean Cancer Patients

NCT01313780 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

128

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer

Interventions

DRUG: Oxycodone/Naloxone
DRUG: Oxycodone(single compound)

Sponsor

Mundipharma Korea Ltd